Abstract
Pain is prevalent and undertreated in nursing home residents, despite the existing wide array of effective pharmacological and nonpharmacological treatment modalities. In order to improve the quality of life of these vulnerable individuals, practitioners require education about the correct approach to assessment and management. Assessment should be comprehensive, taking into account the basic underlying pathology (e.g. osteoarthritis, osteoporosis, peripheral neuropathy, fibromyalgia, cancer) as well as other contributory pathology (e.g. muscle spasm, myofascial pain) and modifying comorbidities (e.g. depression, anxiety, fear, sleep disturbance). Pharmacological management should be guided by a stepped-care approach, modelled after that recommended by the World Health Organization for treatment of cancer pain. Nonopioid and opioid analgesics are the cornerstone of pharmacological pain management. Tricyclic antidepressants and anticonvulsants can be very effective for the treatment of certain types of neuropathic pain. In addition to treating the pain per se, attention should be given to prevention of disease progression and exacerbation, as maintaining function is of prime importance. Nursing home residents with severe dementia challenge the practitioner’s pain assessment skills; an empirical approach to treatment may sometimes be warranted. The success of treatment should be measured by improvement in pain intensity as well as physical, psychosocial and cognitive function. Effective pain management may impact any or all of these functional domains and, therefore, substantially improve the nursing home resident’s quality of life.
Similar content being viewed by others
References
Roy R, Thomas M. A survey of chronic pain in an elderly population. Can Fam Physician 1986; 32: 513–6
Ferrell BA, Ferrell BR, Osterweil D. Pain in the nursing home. J Am Geriatr Soc 1990; 38: 409–14
Sengstaken EA, King SA. The problem of pain and its detection among geriatric nursing home residents. J Am Geriatr Soc 1994; 41: 541–4
Parmelee PA. Assessment of pain in the elderly. In: Lawton MP, Teresi J, editors. Annual review of gerontology and geriatrics. New York (NY): Springer, 1994: 281–301
Weiner D, Peterson B, Ladd K, et al. Pain in nursing home residents: an exploration of prevalence, staff perspectives and practical aspects of measurement. Clin J Pain 1999; 15(2): 92–101
Weiner DK, Peterson B, Logue P, et al. Predictors of pain self-report in nursing home residents. Aging Clin Exp Res 1998; 10: 411–20
Casten RJ, Parmelee PA, Kleban MH, et al. The relationships among anxiety, depression, and pain in a geriatric institutionalized sample. Pain 1995; 61: 271–6
Romano JM, Turner JA. Chronic pain and depression: does the evidence support a relationship? Psychol Bull 1985; 97: 18–34
Williams AK, Schulz R. Association of pain and physical dependency with depression in physically ill middle-aged and elderly. Phys Ther 1988; 68(8): 1226–30
Magni G, Caldieron C, Rigatti-Luchini S, et al. Chronic musculoskeletal pain and depressive symptoms in the general population: an analysis of the 1st National Health and Nutrition Examination Survey data. Pain 1990; 43: 299–307
Williamson GM, Schulz R. Pain, activity restriction, and symptoms of depression among community-residing adults. J Gerontol 1992; 47: 367–72
Cohen-Mansfield J, Marx MS. Pain and depression in the nursing home: corroborating results. J Gerontol 1993; 48: 96–7
Fordyce WE. Evaluating and managing chronic pain. Geriatrics 1978; 33: 59–62
Kewman DG, Vaishampayma N, Zald D, et al. Cognitive impairment in musculoskeletal pain patients. Int J Psychiatr Med 1991; 21: 253–62
Eccleston C, Crombez G, Aldrich S, et al. Attention and somatic awareness in chronic pain. Pain 1997; 72: 209–15
Lavsky-Shulan M, Wallace RB, Kohout FJ, et al. Prevalence and functional correlates of low back pain in the elderly: the Iowa 65+ Rural Health Study. J Am Geriatr Soc 1985; 33: 23–8
Gentili A, Weiner DK, Kuchibhatla M, et al. Factors that disturb sleep in nursing home residents. Aging Clin Exp Res 1997; 9: 207–13
Wilson KG, Watson ST, Currie SR. Daily diary and ambulatory activity monitoring of sleep in patients with insomnia associated with chronic musculoskeletal pain. Pain 1998; 75: 75–84
Scudds RJ, Robertson JM. Empirical evidence of the association between the presence of musculoskeletal pain and physical disability in community-dwelling senior citizens. Pain 1998; 75: 229–35
Guccione AA, Felson DT, Anderson JJ. Defining arthritis and measuring functional status in elders: methodological issues in the study of disease and physical disability. Am J Pub Health 1990; 80(8): 945–9
Lichtenstein MJ, Dhanda R, Cornell JE, et al. Disaggregating pain and its effect on physical functional limitations. J Gerontol A Biol Sci Med Sci 1998; 53A: M361–M371
Moss MS, Lawton MP, Glicksman A. The role of pain in the last year of life in older persons. J Gerontol 1991; 46: P51–7
Skevington SM. Investigating the relationship between pain and discomfort and quality of life, using the WHOQOL. Pain 1998; 76(3): 395–406
US Senate Special Committee on Aging. 1990
Kemper P, Murtaugh CM. Lifetime use of nursing home care. N Engl J Med 1991; 324: 595–600
Bernabei R, Gambassi G, Lapane K, et al. Management of pain in elderly patients with cancer. JAMA 1998; 279(23): 1877–82
Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994; 330: 592–6
Won A, Lapane K, Gambassi G, et al. Correlates and management of nonmalignant pain in the nursing home. J Am Geriatr Soc 1999; 47(8): 936–42
Feldt KS, Ryden MB, Miles S. Treatment of pain in cognitively impaired compared with cognitively intact older patients with hip-fracture. J Am Geriatr Soc 1998; 46: 1079–85
Marks RM, Sachar EJ. Undertreatment of medical inpatients with narcotic analgesics. Ann Intern Med 1973; 78: 173–81
Charap AD. The knowledge, attitudes, and experience of medical personnel treating pain in the terminally ill. Mt Sinai J Med 1978; 45: 561–80
Hanlon JT, O’Brien JG. The pharmacological management of the elderly patient with terminal cancer pain. J Ger Drug Ther 1989; 3: 5–30
Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997; 157(14): 1531–6
Williams B, Betley C. Inappropriate use of nonpsychotropic medications in the nursing home. J Am Geriatr Soc 1995; 43: 513–9
Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med 1995; 123(3): 195–204
Wolfe F, Ross K, Anderson J, et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19–28
Yunus MB, Holt GS, Masi AT, et al. Fibromyalgia syndrome among the elderly-comparison with younger patients. J Am Geriatr Soc 1988; 36: 987–95
Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia-report of the multicenter criteria committee. Arthritis Rheum 1990; 33: 160–72
Vlaeyen JWS, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 2000; 85: 317–32
Weiner DK, Rudy TE. Attitudinal barriers to effective pain management in the nursing home. In: Devor M, Rowbotham MC, Wiesenfeld-Hallin Z, editors. Proceedings of the 9th World Congress on Pain, Progress in Pain Research and Management. Vol. 16. Seattle (WA): IASP Press, 2000: 1097–103
Farrell MJ, Katz B, Helme RD. The impact of dementia on the pain experience. Pain 1996; 67: 7–15
Hill HE, Kornestsky CH. Studies of anxiety associated with anticipation of pain: effects of morphine. Arch Neurol Psychiatry 1952; 67: 612–9
Strang P. Existential consequences of unrelieved cancer pain. Palliat Med 1997; 11: 229–305
Roland M, Morris R. A study of the natural history of back pain-part I: development of a reliable and sensitive measure of disability in low-back pain. Spine 1983; 8: 141–4
Melzack R. The McGill pain questionnaire: major properties and scoring methods. Pain 1975; 1: 277–9
Weiner D, Peterson B, Keefe F. Evaluating persistant pain in long term care residents: what role for pain maps? Pain 1998; 76: 249–57
Gil KM, Phillips G, Abrams MR, et al. Pain drawings and sickle cell disease pain. Clin J Pain 1990; 6: 39–46
Ransford AO, Cairns D, Mooney V. The pain drawing as an aid to the psychologic evaluation of patients with low-back pain. Spine 1976; 1: 127–34
Toomey TC, Gover VF, Jones BN. Site of pain: relationship to measures of pain description, behavior and personality. Pain 1984; 19: 389–97
Tait RC, Chibnall JT, Margolis RB. Pain extent: relations with psychological state, pain severity, pain history and disability. Pain 1990; 41: 295–301
Margolis RB, Tait RC, Krause SJ. Arating system for use with patient pain drawings. Pain 1986; 24: 57–65
Herr KA, Mobily PR, Kohout FJ, et al. Evaluation of the faces pain scale for use with the elderly. Clin J Pain 1998; 14: 29–38
Scherder EJA, Bouma A. Visual analogue scales for pain assessment in Alzheimer’s disease. Gerontology 2000; 46: 47–53
Weiner D, Pieper C, McConnell E, et al. Pain measurement in elders with chronic low back pain: traditional and alternative approaches. Pain 1996; 67: 461–7
Marzinski LR. The tragedy of dementia: clinically assessing pain in the confused nonverbal elderly. J Gerontol Nurs 1991; 17: 25–8
Hurley AC, Volicer BJ, Hanrahan PA, et al. Assessment of discomfort in advanced Alzheimer patients. Res Nurs Health 1992; 15: 369–77
McGrath PA, Brigham MC. The assessment of pain in children and adolescents. In: Turk DC, Melzack R, editors. Handbook of pain assessment. New York (NY): The Guilford Press, 1992: 295–315
Flor H, Fydrich T, Turk DC. Efficacy of multidisciplinary pain treatment centers: a meta-analytic review. Pain 1992; 49: 221–30
Katz S, Ford AB, Moskowitz RW. Studies of illness in the aged — the index of ADL: a standardized measure of biological and psychosocial function. J Am Med Assoc 1963; 185: 914–9
Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983; 17: 37–49
Cohen-Mansfield J, Billing N, Lipson S, et al. Medical correlates of agitation in nursing home residents. Gerontology 1990; 36: 150–8
Duggleby W, Lander J. Cognitive status and postoperative pain: older adults. J Pain Symptom Manage 1994; 9: 19–27
Eccleston C. Chronic pain and attention: a cognitive approach. Br J Clin Psychol 1994; 33: 535–47
Eccleston C. Chronic pain and distraction: an experimental investigation into the role of sustained and shifting attention in the processing of chronic persistent pain. Behav Res Ther 1995; 33(4): 391–405
Lorenz J, Beck H, Bromm B. Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain. Pain 1997; 73: 369–75
Folstein MF, Folstein S, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–98
Lynch EP, Lazor MA, Gellis JE, et al. The impact of postoperative pain on the development of postoperative delirium. Anesth Analg 1998; 86: 781–5
Cook AJ. Cognitive-behavioral pain management for elderly nursing home residents. J Gerontol B Psychol Sci Soc Sci 1998. 53(1): P51–9
Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965; 150(699): 971–9
Henderson CJ, Panush RS. Diets, dietary supplements, and nutritional therapies in rheumatic diseases. Rheum Dis Clin North Am 1999; 25(4): 937–68
Spiro HM. Hope helps: placebos and alternative medicine in rheumatology. Rheum Dis Clin North Am 1999; 25(4): 855–60
Neims AH. Why I would recommend complementary or alternative therapies: a physician’s perspective. Rheum Dis Clin North Am 1999; 25(4): 845–53
Kramer N. Why I would not recommend complementary or alternative therapies: a physician’s perspective. Rheum Dis Clin North Am 1999; 25(4): 833–43
Kanning M. Why I would want to use complementary and alternative therapy: a patient’s perspective. Rheum Dis Clin North Am 1999; 25(4): 823–31
Perlman AI, Eisenberg DM, Panush RS. Talking with patients about alternative and complementary medicine. Rheum Dis Clin North Am 1999; 25(4): 815–22
Vernon H, McDermaid CS, Hagino C. Systematic review of randomized clinical trials of complementary/alternative therapies in the treatment of tension-type and cervicogenic headache. Complement Ther Med 1999; 7(3): 142–55
Berman BM, Swyers JP. Complemenatry medicine treatments for fibromyalgia syndrome. Best Prac Res Clin Rheumatol 1999; 13(3): 487–92
Basmajian JV. The third therapeutic revolution: behavioral medicine. Appl Psychophysiol Biofeedback 1999; 24(2): 107–16
Mulloney SS, Wells-Federman C. Therapeutic touch: a healing modality. J Cardiovasc Nurs 1996; 10(3): 27–49
Berman BM, Swyers JP, Ezzo J. The evidence for acupuncture as a treatment for rheumatologic conditions. Rheum Dis Clin North Am 2000; 26(1): 103–15
Ettinger WHJr, Burns R, Messier SP, et al. A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. The Fitness Arthritis and Seniors Trial (FAST). JAMA 1997; 277(1): 25–31
Stenstrom CH. Home exercise in rheumatoid arthritis functional class II: goal setting versus pain attention. J Rheumatol 1994; 21(4): 627–34
Jacox A, Carr DB, Payne R, et al. Management of cancer pain. Clinical Practice Guideline No. 9. AHCPR Publication No. 94-0592. Rockville (MD): Agency for Health Care Policy and Research. U.S. Department of Health and Human Serivces, Public Health Service, 1994
World Health Organization. Cancer pain relief. 2nd ed. Geneva: World Health Organization, 1996
Divoll M, Abernathy DR, Ameer B, et al. Acetaminophen kinetics in the elderly. Clin Pharmacol Ther 1982; 31: 151–6
Wynne HA, Cope LH, Herd B, et al. The association of age and frailty with paracetamol conjugation in man. Age Ageing 1990; 19(6): 419–24
Bradley JD, Brandt KD, Katz BP, et al. Comparison of an antiinflammatory dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991; 325: 87–91
Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994; 272(23): 1845–50
Gloth FM. Concerns with chronic analgesic therapy in elderly patients. Am JMed 1996; 101(S1a): 19s–24s
Perazella MA, Eras J. Are selective COX-2 inhibitors nephrotoxic? Am J Kidney Dis 2000; 35(5): 937–40
Kaplan-Machlis B, Klostermeyer BS. The cyclo-oxygenase-2 inhibitors: safety and effectiveness. Ann Pharmacother 1999; 33(9): 979–88
Woodhouse KW, Wynne H. The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly. Clin Pharmacokinet 1987; 12: 111–22
Scharf S, Kwiatek R, Ugoni A, et al. NSAIDs and faecal blood loss in elderly patients with osteoarthritis: is plasma half-life relevant? Aust N Z J Med 1998; 28(4): 436–9
Murray MD, Black PK, Kuzmik DD, et al. Acute and chronic effects of nonsteroidal antiinflammatory drugs on glomerular filtration rate in elderly patients. Am J Med Sci 1995; 310(5): 188–97
Gabriel SE, Jaakimainen L, Bombardier C. Risk of serious gastrointestinal complications related to use of nonsteroidal antiinflammatory drugs: a meta-analysis. Ann Intern Med 1991; 115: 787–96
Wolfe MM, Lichtenstein DR, Singh G. Medical progress: gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999; 340(24): 1888–99
Perazella MA, Eras J. Are selective COX-2 inhibitors nephrotoxic? Am J Kidney Dis 2000; 35(5): 188–97
Anon. Drugs for rheumatoid arthritis. Med Lett Drugs Ther 2000; 42(1082): 57–64
Hanlon JT, Schmader KE, Landerman LR, et al. Relation of prescription nonsteroidal anti-inflammatory drug use and cognitive function among community dwelling elderly. Ann Epidemiol 1997; 7: 87–94
Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly-incidence, prevention, and management. Drug Saf 1999; 21(2): 101–22
Shorr RI, Ray WA, Daugherty JR, et al. Concurrent use of non-steroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. Arch Intern Med 1993; 153(14): 1665–70
Murray MD, Brater DL. Non-steroidal anti-inflammatory drugs. Clin Geriatr Med 1990; 6: 365–97
McLeod PJ, Huang AR, Tamblyn RM, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997; 156(3): 385–91
Forman WB. Opioid analgesic drugs in the elderly. Clin Geriatr Med 1996; 12(3): 489–500
Moertel G, Ahmann DL, Taylor WF, et al. A comparative evaluation of marketed analgesic drugs. N Engl J Med 1972; 286: 813–5
Abraham JL. ACP-ASIM End of Life Care Consensus Panel. Management of pain and spinal cord compression in patients with advanced cancer. Ann Intern Med 1999; 131: 37–46
Watson CP, Babul N. Efficacy of oxycodone in neuropathic pain: a randomized controlled trial in post-herpetic neuralgia. Neurology 1998; 50: 1837–41
Bellville JW, Forrest WH, Miller E, et al. Influence of age on pain relief from analgesics. JAMA 1971; 217: 1835–41
Scott JC, Stanski DR. Decreased fentanyl and alfentanil dose requirements with age: a simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987; 240: 159–65
Kaiko RF. Age and morphine analgesia in cancer patients with postoperative pain. Clin Pharmacol Ther 1980; 28: 823–6
Weinberg DS, Inturrisu CE, Reidenberg B, et al. Sublingual absorption of selected opioid analgesics. Clin Pharmacol Ther 1988; 44(3): 335–42
Stanski DR, Greenblatt DJ, Lowenstein E. Kinetics of intravenous and intramuscular morphine. Clin Pharmacol Ther 1978; 24: 52–9
Kaiko RF, Wallenstein SL, Rogers AG, et al. Narcotics in the elderly. Med Clin North Am 1982; 66: 1079–89
Owen JA, Sitar DS, Berger L, et al. Age-related morphine kinetics. Clin Pharmacol Ther 1983; 34: 364–8
Baillie SP, Bateman DN, Coates PE, et al. Age and the pharmacokinetics of morphine. Age Ageing 1989; 18(4): 258–62
Chan K, Kendall MJ, Mitchard J, et al. The effect of aging on plasma pethidine concentration. Br J Clin Pharmacol 1975; 2: 297–302
Holmberg L, Odar-Cederlof I, Boreus LO, et al. Comparative disposition of pethidine and norpethidine in the old and young patients. Eur J Clin Pharmacol 1982; 22: 175–9
Herman RJ, McAllister CD, Branch RA, et al. Effects of age on meperidine disposition. Clin Pharmacol Ther 1985; 37: 19–24
Odar-Cederlof I, Boreous LO, Bondesson U, et al. Comparison of renal excretion of meperidine and its metabolites in old and young patients. Eur J Clin Pharmacol 1985; 28: 171–5
Holdsworth MT, Forman WB, Killilea TA, et al. Transdermal fentanyl disposition in elderly subjects. Gerontology 1994; 40: 32–7
Thompson JP, Bower S, Liddle AM, et al. Perioperative pharmacokinetics of transdermal fentanyl in elderly and young adult patients. Br J Anaesth 1998; 81(2): 152–4
Weiner D, Hanlon JT, Studenski S. CNS drug-related falls liability in community dwelling elderly. Gerontology 1998; 44: 217–21
Shorr RI, Griffin MR, Daugherty JR, et al. Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene. J Gerontol 1992; 47: M111–M115
Hanlon JT, Cutson T, Ruby CM. Drug-related falls in the elderly. Top Geriatr Rehabil 1996; 11(3): 38–54
Porter J, Jick H. Addiction rare in patients treated with narcotics [letter]. N Engl J Med 1980; 302: 123
Coursey CE. The psychomimetic side effects of pentazocine. Drug Intell Clin Pharm 1978; 12: 341–6
Watson CP, Vernich L, Chipman M, et al. Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial. Neurology 1998; 51(4): 1166–71
Godfrey RG. A guide to the understanding and use of tricyclic antidepressants in the overall management of fibromyalgia and other chronic pain syndromes. Arch Intern Med 1996; 156: 1047–52
Glassman AH. Cardiovascular effects of antidepressant drugs: updated. Int Clin Psychopharmacol 1998; 13 Suppl 5: S25–30
Max MB, Lynch SA, Muir J, et al. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326(19): 1250–6
Jung AC, Stalger T, Sulivan M. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. J Gen Intern Med 1997; 12: 384–9
Goldenberg D, Mayskiy M, Mossey C, et al. A randomized, couble-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996; 39(11): 1852–9
Sweet WH. The treatment of trigeminal neuralgia (tic douloureux). N Engl J Med 1986; 315(3): 174–7
Faught E. Epidemiology and drug treatment of epilepsy in elderly people. Drugs Aging 1999; 15: 255–69
Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 1998; 280(21): 1837–42
Backonja M, Beydoun A, Edwards DR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998; 280(2): 1831–6
Allen NB, Studenski SA. Polymyalgia rheumatica and temporal arteritis. Med Clin North Am 1986; 70(2): 369–84
Keltner JL. Giant cell arteritis: signs and symptoms. Ophthalmology 1982; 89: 1101–10
Rains C, Bryson HM. Topical capsaicin: a review of its pharmacological properties and therapeutic potential in postherpetic neuralgia, diabetic neuropathy and osteoarthritis. Drugs Aging 1995; 7(4): 317–28
Watson CP. Topical capsaicin as an adjuvant analgesic. J Pain Symptom Manage 1994; 9(7): 425–33
Anon. Tramadol — a new analgesic. Med Lett Drugs Ther 1995; 37: 59–60
Harati Y, Gooch C, Swenson J, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998; 50(6): 1842–6
Anon. Tramadol. In: Drug facts and comparisons. St. Louis (MO): Wolters Kluwer, 2000: 817–8
Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997; 73: 123–39
Menke JJ, Heins JR. Treatment of postherpetic neuralgia. J Am Pharm Assoc 1999; 39(2): 217–21
Lipman AG. Analgesic drugs for neuropathic and sympathetically maintained pain. Clin Geriatr Med 1996; 12(3): 501–15
Baron R, Wasner G, Lindner V. Optimal treatment of phantom limb pain in the elderly. Drugs Aging 1998; 12(5): 361–76
Johnson RW. Herpes zoster and postherpetic neuralgia. Optimal treatment. Drugs Aging 1997; 10(2): 80–94
Fedele D, Giugliano D. Peripheral diabetic neuropathy: concurrent recommendations and future prospects for its prevention and management. Drugs 1997; 54(3): 414–21
MacFarlane BV, Wright A, O’Callaghan J, et al. Chronic neuropathic pain and its control by drugs. Pharmacol Ther 1997; 75(1): 1–19
Goldenberg DL. Fibromyalgia syndrome a decade later. What have we learned? Arch Intern Med 1999; 159: 777–85
Leventhal LJ. Management of fibromyalgia. Ann Intern Med 1999; 131(11): 850–8
McAlindon TE, Jacques P, Zhang Y, et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum 1996; 39(4): 648–56
Schnitzer T, Bone HG, Crepaldi G, et al., for the Alendronate Once-Weekly Study Group. Therapeutic equivalence of alendronate 70mg once-weekly and alendronate 10mg daily in the treatmen of osteoporosis. Aging Clin Exp Res 2000; 12: 1–12
Maksymowych WP. Managing acute osteoporotic vertebral fractures with calcitonin. Can Fam Physician 1998; 44: 2160–6
AGS Panel on Chronic Pain in Older Persons. The management of chronic pain in older persons. J Am Geriatr Soc 1998; 46: 635–51
Acknowledgements
Financial support was provided by grants from the National Institute on Aging (K08 AG00643 — Dr Weiner; AG15432 amd AG14158 — Dr Hanlon).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weiner, D.K., Hanlon, J.T. Pain in Nursing Home Residents. Drugs & Aging 18, 13–29 (2001). https://doi.org/10.2165/00002512-200118010-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-200118010-00002